Incidence of Seizure Exacerbation and Seizures Reported as Adverse Events during Adjunctive Treatment with Eslicarbazepine Acetate: A Pooled Analysis of Three Phase III Controlled Trials

Authors

Mar Carreño, Epilepsy Unit
Selim Benbadis, University of South FloridaFollow
Francisco Rocha, Portela & Ca., S.A., S. Mamede do Coronado
David Blum, Sunovion Pharmaceuticals Inc
Hailong Cheng, Sunovion Pharmaceuticals Inc

Document Type

Article

Publication Date

2017

Digital Object Identifier (DOI)

https://doi.org/10.1002/epi4.12083

Rights Information

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Was this content written or created while at USF?

Yes

Citation / Publisher Attribution

Epilepsia Open, v. 2, issue 4, p. 459-466

Scholar Commons Citation

Carreño, Mar; Benbadis, Selim; Rocha, Francisco; Blum, David; and Cheng, Hailong, "Incidence of Seizure Exacerbation and Seizures Reported as Adverse Events during Adjunctive Treatment with Eslicarbazepine Acetate: A Pooled Analysis of Three Phase III Controlled Trials" (2017). Neurology Faculty Publications. 76.
https://digitalcommons.usf.edu/neur_facpub/76